What top creators are saying about Sciwind Biosciences Co., Ltd.(NA931)
A clinical-stage metabolic research drug candidate (GLP-1 agonist) developed for weight loss without muscle loss.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Sciwind Biosciences Co., Ltd. in the last 30 days yet.
Top creators covering Sciwind Biosciences Co., Ltd. (NA931)
The 1 sources with the most insights about Sciwind Biosciences Co., Ltd. on Kazuha.
Latest insights about Sciwind Biosciences Co., Ltd. (NA931)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, April 29, 2026
Represents the next frontier of metabolic research; however, there is skepticism regarding its profile of weight loss without injections or muscle loss.
Wednesday, April 29, 2026
Represents the next frontier of metabolic research; however, there is skepticism regarding its profile of weight loss without injections or muscle loss.
Frequently asked
Which podcasters and creators cover Sciwind Biosciences Co., Ltd. (NA931) the most?
The most active sources covering Sciwind Biosciences Co., Ltd. (NA931) on Kazuha are Andreessen Horowitz. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Sciwind Biosciences Co., Ltd. (NA931) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Sciwind Biosciences Co., Ltd. (NA931) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.